| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.091 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |